Spiro-piperidine derivatives as via receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/10 (2006.01) A61P 9/00 (2006.01) C07D 491/10 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2670674

The present invention is concerned with novel indol-2-yl-carbonyl-spiro-piperidine derivatives as VIa receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases. The compounds of present invention are represented by the general formula (I) wherein R1 to R1, X and Y are as defined in the specification.

Cette invention concerne des dérivés d'indol-2-yl-carbonyl-pipéridine en tant qu'antagonistes du récepteur V1a, leur fabrication, des compositions pharmaceutiques les renfermant et leurs utilisations en tant que médicaments. Les composés actifs de l'invention conviennent pour la prévention et/ou le traitement de l'angoisse et des troubles à caractère dépressif et autres pathologies. Les composés de cette invention sont représentés par la formule générale (I) dans laquelle R1 à R1, X et Y sont comme définis dans le descriptif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Spiro-piperidine derivatives as via receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spiro-piperidine derivatives as via receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-piperidine derivatives as via receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1888195

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.